查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1843653

2025年全球癌症診斷人工智慧市場報告

Artificial Intelligence In Cancer Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工智慧在癌症診斷領域的市場規模呈指數級成長，預計從2024年的3.9億美元成長到2025年的5.2億美元，複合年成長率達32.6%。預測期內的成長可歸因於癌症發生率的上升、巨量資料的可用性、個人化腫瘤學的興起、精準醫療的努力以及基因組數據的整合。

預計未來幾年，人工智慧在癌症診斷領域的市場規模將呈指數級成長，到2029年將達到15.4億美元，複合年成長率（CAGR）為31.1%。預測期內的成長主要受以下因素驅動：臨床醫生短缺、人口老化、遠距遠端醫療的全球普及、人工智慧與電子健康記錄的整合以及癌症篩檢計畫的增加。預測期內的關鍵趨勢包括：人工智慧演算法的快速發展、成像技術的進步、病理學的創新、放射組學和放射基因組學的進步、藥物研發、深度學習以及用於預測性生物標記發現的人工智慧。

人工智慧（AI）在癌症診斷中的應用，是指運用先進的計算技術和演算法來輔助癌症的檢測、診斷和表徵。這項技術旨在提高癌症影像檢查的速度、準確性和效率，並力求在檢測乳房X光攝影異常方面達到與放射科醫師相當的準確度。

人工智慧在癌症診斷中的主要組成部分包括軟體解決方案、硬體和服務。軟體解決方案是指為滿足特定業務需求而客製化的應用程式或系統。癌症診斷中的人工智慧軟體利用機器學習演算法和電腦視覺技術分析醫學影像、基因數據和臨床記錄，從而實現精準的癌症檢測、分類和治療預測。這些人工智慧應用已應用於多種癌症，包括乳癌、肺癌、攝護腺癌、大腸癌和腦腫瘤。其應用涵蓋篩檢、診斷、腫瘤識別、監測和治療計劃制定，並被醫院、醫學研究機構、診斷中心和受託研究機構廣泛使用。

美國2025年關稅上調及其引發的貿易緊張局勢正對資訊科技產業產生重大影響，尤其是在硬體製造、資料基礎設施和軟體部署方面。進口半導體、電路基板和網路設備的關稅提高，並推高了高科技公司、雲端服務供應商和資料中心的生產和營運成本。在全球範圍內採購筆記型電腦、伺服器和消費電子產品零件的公司面臨更長的前置作業時間和價格壓力。同時，對專用軟體徵收的關稅以及主要國際市場的報復性措施擾亂了全球IT供應鏈，並降低了海外對美國製造技術的需求。為了應對這些挑戰，該行業正在加大對國內晶片生產的投資，擴大供應商網路，並利用人工智慧驅動的自動化技術來增強韌性並更有效地控制成本。

《人工智慧在癌症診斷中的應用市場研究報告》是商業研究公司最新發布的系列報告之一，提供人工智慧在癌症診斷領域的市場統計數據，包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢和商業機會。本市場研究報告對該行業的現狀和未來發展趨勢進行了深入分析，為您提供全面全面的市場概覽。

未來五年31.1%的成長率預測較先前的預測略微下調了0.1%。這一下調主要歸因於美國與其他國家之間的關稅影響。關稅可能透過增加人工智慧驅動的切片檢查分析系統和病理工具的成本，尤其是德國和日本製造的產品，來抑制醫療保健創新。此外，相互關稅以及不斷升級的貿易緊張局勢和限制措施對全球經濟和貿易造成的負面影響也將使這種影響更加廣泛。

癌症發生率的不斷上升預計將推動人工智慧在癌症診斷市場的發展。癌症的特徵是細胞不受控制地增殖，影響多個器官，是全球發病率和死亡率的重要原因。人工智慧在癌症診斷中發揮關鍵作用，它能夠對醫學影像數據進行準確且有效率的分析，有助於早期發現和準確分類癌變病灶。例如，總部位於瑞士的政府間組織—世界衛生組織（WHO）在2024年2月報告稱，2022年全球新增癌症病例約2,000萬例，死亡人數約970萬。據估計，癌症確診五年後，約有5,350萬人仍存活。因此，癌症發生率的不斷上升預計將推動人工智慧在癌症診斷市場的發展。

醫療基礎設施的持續加強預計將在短期內推動人工智慧在癌症診斷市場的發展。醫療基礎設施涵蓋了支撐醫療服務的基本框架、設施、資源和流程，對於人工智慧技術的無縫整合至關重要。強大的醫療基礎設施能夠將人工智慧融入臨床工作流程，確保資料安全和隱私，並促進醫療機構之間的協作。值得注意的是，澳洲衛生與老年護理部於2022年3月宣布，將在2022-2023會計年度和2025-2026會計年度分別撥款1,320億美元和1,400億美元用於醫療基礎建設。未來四年總計5,370億美元的投入，凸顯了醫療基礎設施的改善在推動人工智慧在癌症診斷市場發展中的關鍵作用。

技術進步已成為人工智慧在癌症診斷市場中日益顯著的發展趨勢。領先的市場參與者正致力於開發針對各種癌症的創新工具，從而鞏固其市場地位。例如，總部位於新加坡的Qritive公司於2023年3月推出了QAi Prostate，這是一款用於前列腺癌診斷的先進人工智慧工具。 QAi Prostate專注於為病理學家提供人工智慧解決方案。它能夠準確識別前列腺癌區域，並對切片檢查組織樣本中的惡性腫瘤和良性腫瘤區域進行分類。該工具提供每張切片或感興趣區域中腫瘤大小和百分比的詳細摘要，幫助病理學家快速做出明智的決策。

在癌症診斷人工智慧市場中，領先企業正積極尋求策略聯盟，將其視為加速人工智慧技術部署的關鍵途徑。此類夥伴關係能夠充分利用合作企業的優勢和資源，並實現互利共贏。例如，2023年10月，羅氏公司(F. Hoffmann-La Roche AG)與Ibex Medical Analytics和亞馬遜網路服務(AWS)達成合作。透過此次合作，病理實驗室將能夠使用navify數位病理軟體平台，並利用Ibex的人工智慧決策支援功能，輔助醫師診斷乳癌和攝護腺癌。 Ibex Medical Analytics、羅氏和AWS之間的夥伴關係將打造創新的人工智慧流程，加速數位病理學的發展，並為病理實驗室提供可擴展的解決方案。

2022年1月，總部位於美國的放射學資訊技術解決方案公司RadNet收購了Aidence Holding BV和Quantib BV。此次策略性收購旨在利用人工智慧技術，拓展肺癌和攝護腺癌診斷與篩檢領域的機會。總部位於荷蘭的Aidence Holding BV專注於肺癌診療流程中的人工智慧臨床應用，而Quantib BV則專注於前列腺癌的人工智慧和機器學習解決方案。

癌症診斷人工智慧市場的主要參與者包括微軟公司、輝瑞公司、強生公司、西門子、羅氏控股公司、Google有限責任公司、國際商業機器公司、賽默飛世爾科技公司、甲骨文公司、通用電氣醫療集團、Illumina公司、Bio-Rad Laboratorophcoco、Healthtiron Health公司、Tempus Labs、Paige AIco、Acco 這些公司、Dock、Healthtiron HealthSel、Apia Labs Diagnostics公司、Prognos Health公司、Aidence公司、Kheiron Medical Technologies Limited公司、Zebra Medical Vision公司、Niramai公司、Enlitic公司、Therapixel公司、Medial EarlySign Ltd.公司、Freenome公司和SkinVision BV公司。

2024年，北美是人工智慧癌症診斷市場最大的區域。預計亞太地區將在預測期內成為成長最快的區域。這份人工智慧癌症診斷市場報告涵蓋亞太地區、西歐、東歐、北美、南美以及中東和非洲。

癌症診斷人工智慧市場報告涵蓋的國家包括澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、西班牙和加拿大。

癌症診斷人工智慧（AI）市場由提供數據分析、影像識別、個人化醫療和決策支援等服務的營業單位所獲得的收入所構成。市場價值還包括服務供應商銷售的任何相關商品或包含在其服務產品中的任何商品的價值。癌症診斷人工智慧（AI）市場還包括基於人工智慧的診斷工具、預測分析工具和虛擬腫瘤委員會的銷售。該市場的價值為“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務的價值。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人工智慧在癌症診斷的應用：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球癌症診斷人工智慧市場：成長率分析
  • 全球癌症診斷人工智慧市場表現：規模與成長，2019-2024年
  • 全球癌症診斷人工智慧市場預測：規模與成長，2024-2029年，2034年
  • 全球癌症診斷人工智慧：潛在市場規模 (TAM)

第6章 市場細分

  • 全球癌症診斷人工智慧市場：按組件、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 軟體解決方案
  • 硬體
  • 服務
  • 全球癌症診斷人工智慧市場（按癌症類型、效能和預測分類，2019-2024年、2024-2029年、2034年）
  • 乳癌
  • 肺癌
  • 攝護腺癌
  • 大腸直腸癌
  • 腦腫瘤
  • 其他
  • 全球癌症診斷人工智慧市場：按應用、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 篩檢和診斷
  • 腫瘤識別
  • 監測
  • 治療
  • 全球癌症診斷人工智慧市場（按最終用戶、效能和預測分類，2019-2024年、2024-2029年、2034年）
  • 醫院
  • 醫學研究所
  • 診斷中心
  • 受託研究機構
  • 全球癌症診斷人工智慧市場：軟體解決方案細分、類型、效能和預測（2019-2024年、2024-2029年、2034年）
  • 影像分析軟體
  • 預測分析軟體
  • 決策支援系統
  • 資料管理平台
  • 全球癌症診斷人工智慧市場：硬體細分、類型、效能和預測（2019-2024年、2024-2029年、2034年）
  • 影像設備
  • 生物標記檢測裝置
  • 計算基礎設施
  • 全球癌症診斷人工智慧市場：服務細分、類型、效能和預測（2019-2024年、2024-2029年、2034年）
  • 諮詢服務
  • 實施服務
  • 維護和支援服務
  • 培訓服務

第7章 區域和國家分析

  • 全球癌症診斷人工智慧市場：按地區、績效和預測分類，2019-2024年、2024-2029年、2034年
  • 全球癌症診斷人工智慧市場按國家分類、表現及預測（2019-2024 年、2024-2029 年、2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 人工智慧在癌症診斷市場的應用：競爭格局
  • 人工智慧在癌症診斷市場的應用：公司概況
    • 微軟公司概況、產品和服務、策略和財務分析
    • 輝瑞公司概況、產品和服務、策略和財務分析
    • 強生公司概況、產品與服務、策略與財務分析
    • 西門子概覽、產品與服務、策略與財務分析
    • 羅氏控股公司概況、產品與服務、策略與財務分析

第31章：其他領先和創新企業

  • Google LCC
  • International Business Machines Corporation
  • Thermo Fisher Scientific Inc.
  • Oracle Corporation
  • GE Healthcare
  • Illumina Inc.
  • Bio Rad Laboratories Inc.
  • Flatiron Health
  • Tempus Labs Inc.
  • Paige AI Inc.
  • OncoHealth Corporation
  • Path AI Inc.
  • Aidoc
  • Sophia Genetics SA
  • Digital Diagnostics Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年人工智慧在癌症診斷市場的應用：提供新機會的國家
  • 2029年人工智慧在癌症診斷市場的應用：新興領域蘊藏新的機會
  • 2029年人工智慧在癌症診斷市場的應用：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r24683u

Artificial intelligence (AI) in cancer diagnostics involves the application of advanced computational techniques and algorithms to aid in the detection, diagnosis, and characterization of cancer. This technology is employed to enhance the speed, accuracy, and efficiency of cancer imaging tests, achieving comparable accuracy to radiologists in detecting mammographic abnormalities.

The main components of artificial intelligence in cancer diagnostics include software solutions, hardware, and services. Software solutions are customized applications or systems designed to address specific business needs, and AI-powered software in cancer diagnostics utilizes machine learning algorithms and computer vision techniques to analyze medical images, genetic data, and clinical records. This enables accurate cancer detection, classification, and treatment prediction. These AI applications are utilized in various types of cancer such as breast cancer, lung cancer, prostate cancer, colorectal cancer, and brain tumors. They are applied in screening and diagnosis, tumor identification, surveillance, and treatment planning and are used by hospitals, medical research institutes, diagnostic centers, and contract research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.

The artificial intelligence in cancer diagnostics research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in cancer diagnostics market statistics, including the artificial intelligence in cancer diagnostics industry's global market size, regional shares, competitors with an artificial intelligence in cancer diagnostics market share, detailed artificial intelligence in cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in cancer diagnostics industry. This artificial intelligence in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.39 billion in 2024 to $0.52 billion in 2025 at a compound annual growth rate (CAGR) of 32.6%. The growth in the historic period can be attributed to increased cancer incidence, big data availability, rise of personalized oncology, precision medicine initiatives, integration of genomic data.

The artificial intelligence in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.54 billion in 2029 at a compound annual growth rate (CAGR) of 31.1%. The growth in the forecast period can be attributed to clinician shortages, population aging, global telemedicine adoption, integration of ai with electronic health records, growing cancer screening programs. Major trends in the forecast period include rapid advances in ai algorithms, advancements in imaging technology, technological innovations in pathology, advancements in radiomics and radiogenomics, drug development, deep learning, ai for predictive biomarker discovery.

The forecast of 31.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Healthcare innovation might be hindered as tariffs increase costs for AI-powered biopsy analysis systems and pathology tools, especially those manufactured in Germany and Japan The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer is anticipated to drive the growth of artificial intelligence in the cancer diagnostics market in the future. Cancer is characterized by uncontrolled cell growth affecting various organs, contributing significantly to morbidity and mortality worldwide. Artificial intelligence plays a crucial role in cancer diagnostics by enabling accurate and efficient analysis of medical imaging data, which aids in the early detection and precise classification of cancerous lesions. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that in 2022, there were approximately 20 million new cancer cases, resulting in 9.7 million deaths. An estimated 53.5 million individuals were alive five years after their cancer diagnosis. Therefore, the rising prevalence of cancer is expected to boost the growth of artificial intelligence in the cancer diagnostics market.

The ongoing enhancement of healthcare infrastructure is poised to drive the artificial intelligence in cancer diagnostics market in the foreseeable future. Healthcare infrastructure, encompassing the fundamental framework, facilities, resources, and processes supporting healthcare services, is crucial for the seamless integration of AI technologies. A robust healthcare infrastructure enables the incorporation of AI into clinical workflows, ensures data security and privacy, and facilitates collaborative efforts across healthcare institutions. Notably, in March 2022, the Department of Health and Aged Care in Australia announced a substantial allocation of $132 billion to healthcare infrastructure in 2022-23, rising to $140 billion in 2025-26. This commitment of $537 billion over the next four years underscores the pivotal role of improving healthcare infrastructure in propelling the artificial intelligence in cancer diagnostics market.

Technological advancement emerges as a prominent trend gaining momentum in the artificial intelligence in the cancer diagnostics market. Key market players are focused on developing innovative tools catering to various cancer conditions, thereby fortifying their market positions. For instance, in March 2023, Qritive, a Singapore-based company specializing in AI-powered solutions for pathologists, introduced QAi Prostate-an advanced AI-powered tool for prostate cancer diagnosis. QAi Prostate accurately identifies prostatic adenocarcinoma regions and classifies malignant and benign tumor areas in biopsy tissue samples. This tool provides detailed summaries of tumor size and percentage for each slide or region of interest, empowering pathologists to make informed decisions rapidly.

Strategic collaborations are a significant approach adopted by major companies operating in the artificial intelligence in cancer diagnostics market to expedite the deployment of AI-powered technologies. Such partnerships leverage the strengths and resources of collaborating entities for mutual benefits. For instance, in October 2023, F. Hoffmann-La Roche AG collaborated with Ibex Medical Analytics and Amazon Web Services. This collaboration allows pathology labs to utilize the navify Digital Pathology software platform to access Ibex's AI-powered decision support capabilities, aiding physicians in diagnosing breast and prostate cancer. The partnership between Ibex Medical Analytics, Roche, and Amazon Web Services generates innovative AI-powered processes, fostering advancements in digital pathology and offering scalable solutions for pathology laboratories.

In January 2022, RadNet, a US-based radiology information technology solutions company, acquired Aidence Holding B.V. and Quantib B.V. This strategic acquisition addresses opportunities in lung and prostate cancer diagnosis and screening through artificial intelligence. Aidence Holding B.V., based in the Netherlands, focuses on AI-powered clinical applications for the lung cancer pathway, while Quantib B.V. specializes in AI and machine learning solutions for prostate cancer.

Major companies operating in the artificial intelligence in cancer diagnostics market include Microsoft Corporation, Pfizer Inc., Johnson & Johnson's, Siemens, Roche Holding AG, Google LCC, International Business Machines Corporation, Thermo Fisher Scientific Inc., Oracle Corporation, GE Healthcare, Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision, Niramai, Enlitic Inc., Therapixel, Medial EarlySign Ltd., Freenome, SkinVision B.V.

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence (AI) in the cancer diagnostics market consists of revenues earned by entities by providing services such as data analysis, image recognition, personalized medicine, and decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the cancer diagnostics market also includes sales of AI-based diagnostic tools, predictive analytics tools, and a virtual tumor board. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software Solutions; Hardware; Services
  • 2) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Types
  • 3) By Application: Screening And Diagnosis; Tumor Identification; Surveillance; Treatment
  • 4) By End-User: Hospitals; Medical Research Institute; Diagnostic Centers; Contract Research Organization
  • Subsegments:
  • 1) By Software Solutions: Imaging Analysis Software; Predictive Analytics Software; Decision Support Systems; Data Management Platforms
  • 2) By Hardware: Imaging Devices; Biomarkers Detection Equipment; Computing Infrastructure
  • 3) By Services: Consulting Services; Implementation Services; Maintenance And Support Services; Training Services
  • Companies Mentioned: Microsoft Corporation; Pfizer Inc.; Johnson & Johnson's; Siemens; Roche Holding AG; Google LCC; International Business Machines Corporation; Thermo Fisher Scientific Inc.; Oracle Corporation; GE Healthcare; Illumina Inc.; Bio Rad Laboratories Inc.; Flatiron Health; Tempus Labs Inc.; Paige AI Inc.; OncoHealth Corporation; Path AI Inc.; Aidoc; Sophia Genetics SA; Digital Diagnostics Inc.; Prognos Health; Aidence; Kheiron Medical Technologies Limited; Zebra Medical Vision; Niramai; Enlitic Inc.; Therapixel; Medial EarlySign Ltd.; Freenome; SkinVision B.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Cancer Diagnostics Market Characteristics

3. Artificial Intelligence In Cancer Diagnostics Market Trends And Strategies

4. Artificial Intelligence In Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence In Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence In Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence In Cancer Diagnostics Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence In Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence In Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence In Cancer Diagnostics Total Addressable Market (TAM)

6. Artificial Intelligence In Cancer Diagnostics Market Segmentation

  • 6.1. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software Solutions
  • Hardware
  • Services
  • 6.2. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Other Types
  • 6.3. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening And Diagnosis
  • Tumor Identification
  • Surveillance
  • Treatment
  • 6.4. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Medical Research Institute
  • Diagnostic Centers
  • Contract Research Organization
  • 6.5. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Software Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Imaging Analysis Software
  • Predictive Analytics Software
  • Decision Support Systems
  • Data Management Platforms
  • 6.6. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Imaging Devices
  • Biomarkers Detection Equipment
  • Computing Infrastructure
  • 6.7. Global Artificial Intelligence In Cancer Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Implementation Services
  • Maintenance And Support Services
  • Training Services

7. Artificial Intelligence In Cancer Diagnostics Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market

  • 8.1. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Cancer Diagnostics Market

  • 9.1. China Artificial Intelligence In Cancer Diagnostics Market Overview
  • 9.2. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Cancer Diagnostics Market

  • 10.1. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Cancer Diagnostics Market

  • 11.1. Japan Artificial Intelligence In Cancer Diagnostics Market Overview
  • 11.2. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Cancer Diagnostics Market

  • 12.1. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Cancer Diagnostics Market

  • 13.1. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Cancer Diagnostics Market

  • 14.1. South Korea Artificial Intelligence In Cancer Diagnostics Market Overview
  • 14.2. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Cancer Diagnostics Market

  • 15.1. Western Europe Artificial Intelligence In Cancer Diagnostics Market Overview
  • 15.2. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Cancer Diagnostics Market

  • 16.1. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Cancer Diagnostics Market

  • 17.1. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Cancer Diagnostics Market

  • 18.1. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Cancer Diagnostics Market

  • 19.1. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Cancer Diagnostics Market

  • 20.1. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market

  • 21.1. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market Overview
  • 21.2. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Cancer Diagnostics Market

  • 22.1. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Cancer Diagnostics Market

  • 23.1. North America Artificial Intelligence In Cancer Diagnostics Market Overview
  • 23.2. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Cancer Diagnostics Market

  • 24.1. USA Artificial Intelligence In Cancer Diagnostics Market Overview
  • 24.2. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Cancer Diagnostics Market

  • 25.1. Canada Artificial Intelligence In Cancer Diagnostics Market Overview
  • 25.2. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Cancer Diagnostics Market

  • 26.1. South America Artificial Intelligence In Cancer Diagnostics Market Overview
  • 26.2. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Cancer Diagnostics Market

  • 27.1. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Cancer Diagnostics Market

  • 28.1. Middle East Artificial Intelligence In Cancer Diagnostics Market Overview
  • 28.2. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Cancer Diagnostics Market

  • 29.1. Africa Artificial Intelligence In Cancer Diagnostics Market Overview
  • 29.2. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape
  • 30.2. Artificial Intelligence In Cancer Diagnostics Market Company Profiles
    • 30.2.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Johnson & Johnson's Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Cancer Diagnostics Market Other Major And Innovative Companies

  • 31.1. Google LCC
  • 31.2. International Business Machines Corporation
  • 31.3. Thermo Fisher Scientific Inc.
  • 31.4. Oracle Corporation
  • 31.5. GE Healthcare
  • 31.6. Illumina Inc.
  • 31.7. Bio Rad Laboratories Inc.
  • 31.8. Flatiron Health
  • 31.9. Tempus Labs Inc.
  • 31.10. Paige AI Inc.
  • 31.11. OncoHealth Corporation
  • 31.12. Path AI Inc.
  • 31.13. Aidoc
  • 31.14. Sophia Genetics SA
  • 31.15. Digital Diagnostics Inc.

32. Global Artificial Intelligence In Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Cancer Diagnostics Market

34. Recent Developments In The Artificial Intelligence In Cancer Diagnostics Market

35. Artificial Intelligence In Cancer Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence In Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence In Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence In Cancer Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer